NO813850L - Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser

Info

Publication number
NO813850L
NO813850L NO813850A NO813850A NO813850L NO 813850 L NO813850 L NO 813850L NO 813850 A NO813850 A NO 813850A NO 813850 A NO813850 A NO 813850A NO 813850 L NO813850 L NO 813850L
Authority
NO
Norway
Prior art keywords
compound
formula
mixture
carbon atoms
substituent
Prior art date
Application number
NO813850A
Other languages
English (en)
Norwegian (no)
Inventor
David Brown
Robert Ian Dowell
Rodney Brian Hargreaves
Brian Geoffrey Main
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO813850L publication Critical patent/NO813850L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194Radicals derived from thio- or thiono carboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO813850A 1980-11-14 1981-11-13 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser NO813850L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036680 1980-11-14

Publications (1)

Publication Number Publication Date
NO813850L true NO813850L (no) 1982-05-18

Family

ID=10517317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813850A NO813850L (no) 1980-11-14 1981-11-13 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser

Country Status (20)

Country Link
US (4) US4423045A (de)
EP (1) EP0052442B1 (de)
JP (3) JPS57109771A (de)
KR (1) KR830007624A (de)
AU (1) AU7709181A (de)
CA (1) CA1176250A (de)
DD (1) DD202020A5 (de)
DE (1) DE3172252D1 (de)
DK (1) DK498881A (de)
ES (2) ES507126A0 (de)
FI (1) FI813566L (de)
GR (1) GR79554B (de)
HU (1) HU185979B (de)
MW (1) MW4881A1 (de)
NO (1) NO813850L (de)
NZ (1) NZ198967A (de)
PL (2) PL238802A1 (de)
PT (1) PT73995B (de)
ZA (1) ZA817597B (de)
ZW (1) ZW26381A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
ZA827641B (en) * 1981-11-12 1983-09-28 Ici Plc Thiadiazine, oxadiazine and triazine derivatives which possess cardiotonic and/or antihypertensive activity
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
US4657906A (en) * 1982-06-05 1987-04-14 Smith Kline & French Laboratories Ltd. Heterocyclic compounds having inotropic activity
JPS5962578A (ja) * 1982-10-04 1984-04-10 Mitsui Toatsu Chem Inc オキサジアジン誘導体およびそれを含有する医薬組成物
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
JPS59196874A (ja) * 1983-04-22 1984-11-08 Fujisawa Pharmaceut Co Ltd トリアジン誘導体
GB8328907D0 (en) * 1983-10-28 1983-11-30 Smith Kline French Lab Chemical compounds
GB8329784D0 (en) * 1983-11-08 1983-12-14 Smith Kline French Lab Heterocyclic compounds
GB8332313D0 (en) * 1983-12-02 1984-01-11 Smith Kline French Lab Chemical compounds
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
EP0233287B1 (de) 1984-10-04 1991-01-30 Zenyaku Kogyo Kabushikikaisha 1,4-thiazinabkömmlinge, deren herstellung und diese enthaltende kardiotonische mittel
JPS61106574A (ja) * 1984-10-29 1986-05-24 Yoshitomi Pharmaceut Ind Ltd オキサ(またはチア)ジアジン誘導体
DE3531658A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
FR2592878B1 (fr) * 1986-01-16 1988-12-16 Pf Medicament Monoaryl-5 as triazinones-3 substituees en position 2, leur procede de preparation et leur application en tant que medicaments
US4898862A (en) * 1986-03-20 1990-02-06 Sankyo Company Limited 1,2,4-triazinone derivatives, their preparation and use
GB8610369D0 (en) * 1986-04-28 1986-06-04 Smith Kline French Lab Heterocyclic compounds
US4861773A (en) * 1986-04-28 1989-08-29 Smith Kline & French Laboratories Limited Heterocyclic compounds
DE3706427A1 (de) * 1987-02-27 1988-09-08 Boehringer Mannheim Gmbh Neue substituierte 3h-indole, zwischenprodukte, verfahren zu ihrer herstellung sowie arzneimittel
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
DE3913597A1 (de) * 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
TW309520B (de) * 1994-04-26 1997-07-01 Mitsubishi Chem Corp
USRE39263E1 (en) * 1994-05-04 2006-09-05 Bayer Aktiengesellschaft Substituted aromatic thiocarboxylic acid amides and their use as herbicides
US6077813A (en) * 1994-05-04 2000-06-20 Bayer Aktiengesellschaft Substituted aromatic thiocarboxylic acid amides and their use as herbicides
AU6320998A (en) 1997-02-21 1998-09-09 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
DE19929781A1 (de) * 1999-06-29 2001-01-04 Bayer Ag N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung
EP2299267A3 (de) 2005-11-16 2011-05-04 Novartis AG Biomarker zur Anti-NogoA-antikörperbehandlung bei Rückenmarksverletzung
JPWO2011093401A1 (ja) 2010-01-27 2013-06-06 三菱レイヨン株式会社 新規連鎖移動剤及びそれを用いた乳化重合
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
US11897867B2 (en) 2017-08-04 2024-02-13 Bayer Aktiengesellschaft 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer
CN113348165B (zh) 2019-02-01 2024-06-25 拜耳股份有限公司 用于治疗过度增殖性疾病的1,2,4-三嗪-3(2h)-酮化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314455A (en) * 1964-07-24 1967-04-18 Black Clawson Co Band saw resawing machine
US3377345A (en) * 1966-09-23 1968-04-09 Dow Chemical Co Substituted 3, 4, 5, 6-tetrahydro-2h-1, 3, 4-oxadiazin-2-one compounds and method ofpreparation thereof
FR8169M (de) * 1967-05-17 1970-08-31
US3946010A (en) * 1975-04-09 1976-03-23 E. R. Squibb & Sons, Inc. 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
US4097671A (en) * 1975-08-28 1978-06-27 General Electric Company Dihydrooxadiazinones and method for making
US4097425A (en) * 1975-08-28 1978-06-27 General Electric Company Thermoplastic formable blends, a foaming method and products made thereby
US4105848A (en) * 1976-12-27 1978-08-08 General Electric Company Process for the production of dihydrooxadiazinone compounds
ZA827641B (en) * 1981-11-12 1983-09-28 Ici Plc Thiadiazine, oxadiazine and triazine derivatives which possess cardiotonic and/or antihypertensive activity
US4489074A (en) * 1982-11-12 1984-12-18 Imperial Chemical Industries, Plc 1,3,4-Thiadiazin-2-ones
JPH072947B2 (ja) * 1985-06-27 1995-01-18 松下電子工業株式会社 螢光体

Also Published As

Publication number Publication date
DK498881A (da) 1982-05-15
ES8307231A1 (es) 1983-07-01
JPS6236370A (ja) 1987-02-17
EP0052442A1 (de) 1982-05-26
ZA817597B (en) 1982-10-27
US4423045A (en) 1983-12-27
US4587246A (en) 1986-05-06
MW4881A1 (en) 1983-09-14
GR79554B (de) 1984-10-30
CA1176250A (en) 1984-10-16
PT73995A (en) 1981-12-01
JPH0572384B2 (de) 1993-10-12
JPS57109771A (en) 1982-07-08
US4683232A (en) 1987-07-28
PL238802A1 (en) 1983-09-12
DE3172252D1 (en) 1985-10-17
FI813566L (fi) 1982-05-15
ES8401044A1 (es) 1983-11-16
ZW26381A1 (en) 1983-06-01
ES516588A0 (es) 1983-11-16
EP0052442B1 (de) 1985-09-11
DD202020A5 (de) 1983-08-24
JPS6230771A (ja) 1987-02-09
HU185979B (en) 1985-04-28
AU7709181A (en) 1982-05-20
PT73995B (en) 1983-06-20
US4503054A (en) 1985-03-05
PL233809A1 (en) 1983-09-12
ES507126A0 (es) 1983-07-01
KR830007624A (ko) 1983-11-04
NZ198967A (en) 1984-12-14

Similar Documents

Publication Publication Date Title
NO813850L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
US2893992A (en) I ii i i
US4595780A (en) Sulfonamido-benzamide derivatives
US4489073A (en) 1,3,4-Thiadiazin-5-ones
US4694005A (en) 5-phenyl-3H,6H-1,3,4-oxadiazine-2-ones in treatment of heart failure and hypertension
DE69104041T4 (de) Orthosubstituierte biphenylguanidinderivate sowie diese enthaltende antidiabetische oder hypoglykämische mittel.
US4489074A (en) 1,3,4-Thiadiazin-2-ones
US4725608A (en) Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
NZ188770A (en) Thiazolinylguanidine derivatives and pharmaceutical compositions
DD294023A5 (de) Therapeutische mittel
US3726875A (en) 1,3(2h,4h)-dioxoisoquinoline-4-carboxylate esters and process therefor
US6610715B1 (en) Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
US4318915A (en) Substituted guandines and methods of preparation thereof
US5086052A (en) Substituted 1,4,5,6-tetrahydro-2H-pyridazin-3-one and -3-thione compounds having lipoxygenase inhibitory activity
US4970210A (en) Triazinone lipoxygenase compounds
US3674787A (en) 2-(alpha-morpholinobenzyl)-anilides
US5059599A (en) Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their preparation and their use in therapy
DE69016672T2 (de) 4-(hetero)arylmethyloxy-phenyl-diazolderivate, verfahren zu deren herstellung und ihre therapeutische verwendung.
US4152518A (en) Halogenated thiobenzamides
US5240918A (en) 2-(substituted imino)-thiazolidines and process for the preparation thereof
US4643996A (en) 5-phenyl-2-furoic acid hydrazides
US4328223A (en) 2-Amino-3a,4,5,6-tetrahydro-perimidine derivatives and their medicinal use in combatting circulatory diseases
CS209542B2 (en) Method of making the 2,6-bis(aminoacylamino)-benzo-1,2-d:5,4-d-bisthiazole and 2-amino-6-(aminoacylamino)-benzo 1,2-d:5,4-d-bisthiazole derivatives
CS228531B2 (en) Method for the production of phenylpiperazine derivates
EP0096299A2 (de) Hydroxyimino- und Alkoxyiminoderivate von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen